vs

Side-by-side financial comparison of Freedom Holding Corp. (FRHC) and Genius Sports Ltd (GENI). Click either name above to swap in a different company.

Freedom Holding Corp. is the larger business by last-quarter revenue ($628.6M vs $510.9M, roughly 1.2× Genius Sports Ltd). Freedom Holding Corp. runs the higher net margin — 12.1% vs -12.3%, a 24.5% gap on every dollar of revenue. Freedom Holding Corp. produced more free cash flow last quarter ($651.7M vs $69.6M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 16.3%).

Freedom Holding Corp. is an investment conglomerate registered in Nevada, USA. The company provides a range of services in retail financial securities brokerage and trading, asset management, capital markets, investment research and counseling, investment banking and underwriting services, mortgages, insurance, banking and other consumer services. Its main area of focus is in the American stock market, as well as the markets of Europe and Central Asia, mainly Kazakhstan.

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

FRHC vs GENI — Head-to-Head

Bigger by revenue
FRHC
FRHC
1.2× larger
FRHC
$628.6M
$510.9M
GENI
Higher net margin
FRHC
FRHC
24.5% more per $
FRHC
12.1%
-12.3%
GENI
More free cash flow
FRHC
FRHC
$582.2M more FCF
FRHC
$651.7M
$69.6M
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
16.3%
FRHC

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
FRHC
FRHC
GENI
GENI
Revenue
$628.6M
$510.9M
Net Profit
$76.2M
$-63.0M
Gross Margin
96.0%
25.2%
Operating Margin
14.9%
-11.5%
Net Margin
12.1%
-12.3%
Revenue YoY
-4.1%
Net Profit YoY
-2.6%
EPS (diluted)
$1.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRHC
FRHC
GENI
GENI
Q4 25
$628.6M
$510.9M
Q3 25
$526.1M
$335.4M
Q2 25
$533.4M
$215.2M
Q1 25
$363.7M
$119.7M
Q4 24
$655.2M
$413.0M
Q3 24
$580.9M
$285.8M
Q2 24
$450.7M
$184.1M
Q1 24
$464.7M
$97.2M
Net Profit
FRHC
FRHC
GENI
GENI
Q4 25
$76.2M
$-63.0M
Q3 25
$38.7M
Q2 25
$30.4M
$-47.3M
Q1 25
$-142.7M
$-25.5M
Q4 24
$78.3M
$-85.5M
Q3 24
$114.7M
$-47.1M
Q2 24
$34.4M
$-35.5M
Q1 24
$95.2M
$-25.2M
Gross Margin
FRHC
FRHC
GENI
GENI
Q4 25
96.0%
25.2%
Q3 25
97.1%
24.2%
Q2 25
97.4%
19.1%
Q1 25
96.6%
10.7%
Q4 24
98.6%
16.7%
Q3 24
99.1%
20.5%
Q2 24
99.0%
18.6%
Q1 24
9.8%
Operating Margin
FRHC
FRHC
GENI
GENI
Q4 25
14.9%
-11.5%
Q3 25
11.5%
-15.3%
Q2 25
7.6%
-21.0%
Q1 25
-42.7%
-20.3%
Q4 24
15.0%
-18.0%
Q3 24
22.1%
-13.9%
Q2 24
9.2%
-16.8%
Q1 24
22.5%
-23.7%
Net Margin
FRHC
FRHC
GENI
GENI
Q4 25
12.1%
-12.3%
Q3 25
7.4%
Q2 25
5.7%
-22.0%
Q1 25
-39.2%
-21.3%
Q4 24
11.9%
-20.7%
Q3 24
19.7%
-16.5%
Q2 24
7.6%
-19.3%
Q1 24
20.5%
-25.9%
EPS (diluted)
FRHC
FRHC
GENI
GENI
Q4 25
$1.25
Q3 25
$0.63
Q2 25
$0.50
Q1 25
$-2.35
Q4 24
$1.29
Q3 24
$1.89
Q2 24
$0.57
Q1 24
$1.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRHC
FRHC
GENI
GENI
Cash + ST InvestmentsLiquidity on hand
$869.2M
$280.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.4B
$724.5M
Total Assets
$12.4B
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRHC
FRHC
GENI
GENI
Q4 25
$869.2M
$280.6M
Q3 25
$636.0M
$110.2M
Q2 25
$567.9M
$110.2M
Q1 25
$837.3M
$110.2M
Q4 24
$577.9M
$100.3M
Q3 24
$569.2M
$100.3M
Q2 24
$718.7M
$100.3M
Q1 24
$545.1M
$100.3M
Stockholders' Equity
FRHC
FRHC
GENI
GENI
Q4 25
$1.4B
$724.5M
Q3 25
$1.2B
$572.4M
Q2 25
$1.2B
$572.4M
Q1 25
$1.2B
$572.4M
Q4 24
$1.3B
$573.0M
Q3 24
$1.3B
$573.0M
Q2 24
$1.1B
$573.0M
Q1 24
$1.2B
$573.0M
Total Assets
FRHC
FRHC
GENI
GENI
Q4 25
$12.4B
$1.1B
Q3 25
$10.3B
$792.3M
Q2 25
$9.7B
$792.3M
Q1 25
$9.9B
$792.3M
Q4 24
$9.1B
$775.7M
Q3 24
$8.8B
$775.7M
Q2 24
$8.5B
$775.7M
Q1 24
$8.3B
$775.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FRHC
FRHC
GENI
GENI
Operating Cash FlowLast quarter
$717.8M
$81.9M
Free Cash FlowOCF − Capex
$651.7M
$69.6M
FCF MarginFCF / Revenue
103.7%
13.6%
Capex IntensityCapex / Revenue
10.5%
2.4%
Cash ConversionOCF / Net Profit
9.42×
TTM Free Cash FlowTrailing 4 quarters
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FRHC
FRHC
GENI
GENI
Q4 25
$717.8M
$81.9M
Q3 25
$535.3M
$-4.8M
Q2 25
$480.8M
$-1.2M
Q1 25
$1.3B
$-14.6M
Q4 24
$-72.8M
$14.9M
Q3 24
$-438.0M
$-9.2M
Q2 24
$854.1M
Q1 24
$309.0M
Free Cash Flow
FRHC
FRHC
GENI
GENI
Q4 25
$651.7M
$69.6M
Q3 25
$456.4M
$-14.2M
Q2 25
$450.0M
$-5.8M
Q1 25
$-16.0M
Q4 24
$-92.7M
$11.3M
Q3 24
$-447.5M
$-11.6M
Q2 24
$829.9M
Q1 24
FCF Margin
FRHC
FRHC
GENI
GENI
Q4 25
103.7%
13.6%
Q3 25
86.7%
-4.2%
Q2 25
84.4%
-2.7%
Q1 25
-13.4%
Q4 24
-14.1%
2.7%
Q3 24
-77.0%
-4.1%
Q2 24
184.1%
Q1 24
Capex Intensity
FRHC
FRHC
GENI
GENI
Q4 25
10.5%
2.4%
Q3 25
15.0%
2.8%
Q2 25
5.8%
2.1%
Q1 25
1.2%
Q4 24
3.0%
0.9%
Q3 24
1.6%
0.9%
Q2 24
5.4%
Q1 24
Cash Conversion
FRHC
FRHC
GENI
GENI
Q4 25
9.42×
Q3 25
13.82×
Q2 25
15.82×
Q1 25
Q4 24
-0.93×
Q3 24
-3.82×
Q2 24
24.83×
Q1 24
3.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons